Patents by Inventor Christopher Boissard

Christopher Boissard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240167228
    Abstract: The present disclosure generally relates to a method for providing a barrier coating on a hollow container (100) comprising molded pulp. The method comprises providing a polymeric powder coating onto the interior surface (105a) and at least a portion of the exterior surface of the container (100) prior to curing and/or melting the powder coatings. The present disclosure also relates to a hollow container (100) formed by the method.
    Type: Application
    Filed: March 25, 2022
    Publication date: May 23, 2024
    Inventors: Lars Sandberg, Yselaure Boissard, Shoko Yamada, Andreas Nyström, Christopher T. Karlsson
  • Publication number: 20050064491
    Abstract: An isolated polynucleotide encoding a novel potassium channel polypeptide, KCNQ5, that is expressed primarily in brain and skeletal muscle is described. The new polypeptide has been cloned and isolated from a human brain cDNA library and is a member the KCNQ family of potassium channels. The provided human KCNQ5 nucleic acid sequence and encoded polypeptide can be employed for diagnostic, screening and therapeutic uses.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 24, 2005
    Inventors: Steven Dworetzky, Chandra Ramanathan, Joanne Trojnacki, Christopher Boissard, Valentin Gribkoff
  • Publication number: 20050043293
    Abstract: The present invention describes calcium sensitive and selective maxi-K potassium channel opener/activator compounds that function to open maxi-K channels under conditions of high intracellular calcium concentrations, and which do not significantly affect the opening of maxi-K channel proteins under conditions of low or physiologically normal intracellular calcium concentrations. Methods of assaying for and using such compounds are also provided. According to the invention, whole cell voltage patch-clamp studies newly demonstrated that the ability of opener compounds, e.g., fluoro-oxindoles and chloro-oxindoles, to open maxi-K channels was sensitive to the intracellular Ca2+ concentration ([Ca2+])i, i.e., more channels opened at more negative potentials. Particular fluoro-oxindole and chloro-oxindole compounds produced significant increases in whole-cell maxi-K potassium channel-mediated outward currents only in cells having higher [Ca2+]i, compared with effects in lower [Ca2+]i.
    Type: Application
    Filed: September 28, 2004
    Publication date: February 24, 2005
    Inventors: Valentin Gribkoff, Debra Post-Munson, Sarita Yeola, Christopher Boissard, Piyasena Hewawasam, John Starrett